AbbVie's combination antibiotic Emblaveo has gotten federal approval to treat complicated intra-abdominal infections, making it the first and only such therapy approved to fight antimicrobial ...

White piedra is a superficial fungal infection of the hair. Several species of fungus that live in soil or dirty water can cause it. Piedra is the Spanish word for stone. White piedra appears as ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Jim Cramer, the host of Mad Money, on Tuesday, took a close look at President Donald ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting off on a very different note. According to iSpot.TV’s analysis of ...

Guggenheim raised the firm’s price target on AbbVie (ABBV) to $214 from $212 and keeps a Buy rating on the shares after updating its company model following the company’s “strong” Q4 and ...

Shares of AbbVie (NYSE: ABBV) were jumping 7.1% higher as of 11:10 a.m. ET on Friday after rising as much as 9.2% earlier in the day. The nice gain stemmed from the big drugmaker's 2024 fourth ...

AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit ...

Well before the market open, news broke of those two AbbVie price target increases ... Sign Up For Free » The first came from white-shoe investment bank Goldman Sachs, whose analyst Chris ...

Well before the market open, news broke of those two AbbVie price target increases ... The first came from white-shoe investment bank Goldman Sachs, whose analyst Chris Shibutani bumped his ...